Gear Up for AMC Entertainment (AMC) Q2 Earnings: Wall Street Estimates for Key Metrics

AMC Entertainment (AMC) is projected to report a Q2 loss of -$0.04 per share, a 90.7% year-over-year improvement from a larger loss, on $1.35 billion in revenue, up 30.8% year-over-year. However, the consensus EPS estimate has been significantly revised downward by 255.6% over the past 30 days, indicating a substantially worse loss than previously anticipated. Despite this negative revision, analysts project robust double-digit year-over-year growth across all major revenue segments, including admissions (+32.6%), food and beverage (+30%), and other theatre revenues (+24%), signaling continued operational recovery.

Analysis

AMC Entertainment is approaching its Q2 earnings with a complex and diverging set of expectations. While Wall Street anticipates a significant year-over-year improvement with revenues projected to rise 30.8% to $1.35 billion and the quarterly loss narrowing 90.7% to -$0.04 per share, this outlook is overshadowed by a severe negative revision in near-term sentiment. The consensus EPS estimate has been revised downward by a dramatic 255.6% over the past 30 days, indicating that analysts' initial profitability forecasts have deteriorated substantially. This suggests that despite a strong top-line recovery, driven by projected growth in Admissions (+32.6%), Food and Beverage (+30%), and Other Theatre revenues (+24%), underlying profitability challenges may be more acute than previously thought. The stock's recent performance, a -2.1% return over the past month compared to the S&P 500 composite's +0.5% gain, reflects this growing caution. The Zacks Rank #3 (Hold) reinforces a neutral outlook, suggesting the market is awaiting clarity on whether the robust revenue growth can translate into a sustainable path to profitability.

Key Decisions for Investors

• Investors should focus on the upcoming earnings call for management's explanation of the significant 255.6% downward revision in EPS estimates, as this suggests potential margin pressure despite the projected 30.8% year-over-year revenue growth.
• Given the negative analyst revisions and the stock's recent underperformance against the S&P 500, a cautious stance is warranted, and it may be prudent to await the earnings release before initiating or adding to long positions.
• Monitor whether actual results meet the robust revenue growth forecasts, particularly the $748.23 million estimate for Admissions, but weigh any top-line strength against management's forward guidance on profitability and cost controls.